期刊文献+

不同化疗方案治疗恶性滋养细胞肿瘤的效果比较 被引量:2

Comparison of the efficacy of two kinds of chemotherapy schemes for treatment of gestational trophoblastic tumor
下载PDF
导出
摘要 目的比较不同化疗方案治疗恶性滋养细胞肿瘤的临床效果。方法选取2010—2015年在河南省肿瘤医院治疗的恶性滋养细胞肿瘤患者137例,分为A组和B组,其中A组73例,B组64例。A组采用EMA/CO化疗方案,B组采用5-氟尿嘧啶单药化疗,对两组治疗效果及毒性反应进行比较。结果 A组治疗有效率为91.8%,B组治疗有效率为75.0%,两组有效率比较,差异有统计学意义(P<0.05)。两组骨髓抑制发生率比较,差异无统计学意义(P>0.05);两组口腔黏膜损伤及胃肠道反应(恶心呕吐、腹泻)发生率比较,差异有统计学意义(P<0.05)。结论 EMA/CO化疗方案可以有效治疗恶性滋养细胞肿瘤,且毒副作用轻,患者易于接受,适合在临床中推广应用。 Objective To compare the different efficacy of two kinds of chemotherapy schemes for treatment of gestational tro- phoblasite tumor (GTr). Methods 137 patients with GTT admitted to henan provincial cancer hospital from 2010 to 2015 were divided into EMA/CO chemotherapy group A ( n = 73) and 5 - Fu chemotherapy group B ( n = 64). The effective rate and ad- verse reaction were analyzed and compared between the two groups. Results The effective rate of the group A was 91.8%, the effective rate of the group B was 75.0% , the difference between the two group was signifieant(P 〈0. 05). There was no signifi- cant difference in bone marrow depression between the two groups, hut there were significant differences in nausea and vomiting, diarrhea, and oral ulcer between the two groups. Conclusion EMO/CO chemotherapy scheme can effectively treat the GTr pa- tients, and it is suitable for clinical application.
出处 《河南医学研究》 CAS 2017年第19期3470-3471,共2页 Henan Medical Research
关键词 恶性滋养细胞肿瘤 EMA/CO化疗 5-氟尿嘧啶化疗 gestational trophoblastie tumor EMA/CO chemotherapy 5 -Fu chemotherapy
  • 相关文献

参考文献3

二级参考文献32

  • 1Scully RE, Young RH. Trophoblastic pseudotumor: a reap- praisal. The American Journal of Surgical Pathology, 1981, 5: 75.
  • 2Hassadia A, Gillespie A, Tidy J, et ak Placental site trophoblastie tumour: clinical features and management. Gynecologic oncology, 2005, 99:603 - 607.
  • 3Piura B, Shaco- Levy R. Placental site trophoblastic tumor. Harefuah, 2007, 146: 62.
  • 4Schmid P, Nagai Y, ANarwal R, et al. Prognostic markers and long- term outcome of placental- site trophoblastic tumours: a retrospective observational study. The Lancet, 2009 374: 48 - 55.
  • 5Baergen RN, Joanne L, Young RH, et ak Placental site tropho- blastic tumor: a study of 55 cases and review of the literature em- phasizing factors of prognostic significance Gynecologic oncology, 2006, 100: 511-520.
  • 6Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. The Lancet, 2010. 717-729.
  • 7Feltmate CM, Genest DR, Wise L, et ak Placental site tropho- blastic tumor: a 17- year experience at the New England Tropho- blastic Disease Center. Gynecologic oncology, 2001, 82: 415- 419.
  • 8Machtinger R, Gotlieb WH, Korach J, et al. Placental site trophoblastic tumor: outcome of five cases including fertility preserving management. Gynecologic oncology, 2005, 96 56 - 61.
  • 9Cole LA, Khanlian SA, Muller CY, et aL Gestodional tropho- blastic disease: 3, Human Chorionie gonadotropin- free tbeta Subunit, a reliable rnarber of placental site tropoblastic tumors. Gynecologic Oncology, 2006, 102:160 - 164.
  • 10Chalouhi GE,Golfier F,Soignon P. Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients:efficacy and toxicity[J].Am J Obstet Gynecol,2009,(06):643el-643e6.

共引文献21

同被引文献14

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部